Vicor Technologies Announces Additional Positive Clinical Trial Results
May 15th 2008Drug InformationClinical Trials
Vicor Technologies, Inc. (OTCBB: VCRT) is pleased to announce positive results of a clinical study conducted by the Company, and accepted for publication in the August 2008 issue of Therapeutics and Clinical Risk Management. The study is titled “Risk Stratification for Arrhythmic Death in an Emergency Department Cohort: a new method of nonlinear PD2i analysis of the ECG.” The study enrolled 918 patients (876 of which completed the study) in six emergency departments.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
